Statement of Practice Summary:
Antitrust, Appellate, Asia, Bankruptcy, Biotech, Pharma & Life Science, Chemicals, Collateralized Debt Obligation, Company Secretarial, Construction & Engineering, Corporate & Securities, Corporate Governance, Derivatives, E-commerce, Emerging Companies, Employee Benefits & Executive Compensation, Employee Share Incentives, Employment & Labour, Energy, Environment, Finance, Financial Services, Global Trade, Government, Government Contracts, Health Care, Information Technology, Insurance & Reinsurance, Intellectual Property, International Arbitration, Investment Management, Latin America, Legislative, Litigation & Dispute Resolution, Natural Resources, Outsourcing, Pensions, PPP/PFI & Infrastructure, Private Equity, Private Investment Fund, Pro Bono, Professional Practices, Project Finance, Property Rights, Public Law, Rail, Real Estate, Regulated Industries, Restructuring & Insolvency, Securitisation, Tax Controversy & Transfer Pricing, Tax Transactions & Consulting, Telecommunications & Media, Venture & Technology, Wealth Management.
EU Antitrust Private Damages Actions
Kiran S. Desai,Julian Ellison,Nathalie Jalabert Doury,Robert Klotz,Jens Peter Schmidt, February 27, 2015
On 10 November 2014 the governments of the 28 EU Member States approved a new law that aims at facilitating claims for damages by victims of antitrust infringements in Europe. The new law entered into was adopted on 4 December 2014. The law, which takes the form of an EU Directive, was previously...